tetano
Editor, Senior Moderator
Expert Rev Vaccines. 2013 Jun;12(6):593-6. doi: 10.1586/erv.13.44.
Perspectives on vaccination in adults.
Doerr HW.
Source
Institute for Medical Virology, Goethe University, Frankfurt am Main, Germany. h.w.doerr@em.uni-frankfurt.de.
Abstract
In the Second Conference on Controversies in Vaccination in Adults, leading vaccine experts among manufacturers, physicians, microbiologists, virologists, immunologists and public health specialists came together to discuss recent approaches, developments and strategies in vaccination against worldwide pressing epidemic and endemic infectious diseases (pneumococcal, staphylococcal, influenza, papillomavirus-associated tumors, varicella-zoster, AIDS and tuberculosis), and noninfectious epidemics (atherosclerosis and smoking) outlining arguments surrounding the progress of vaccines.
PMID:
23750790
[PubMed - in process]
http://www.ncbi.nlm.nih.gov/pubmed/23750790
Perspectives on vaccination in adults.
Doerr HW.
Source
Institute for Medical Virology, Goethe University, Frankfurt am Main, Germany. h.w.doerr@em.uni-frankfurt.de.
Abstract
In the Second Conference on Controversies in Vaccination in Adults, leading vaccine experts among manufacturers, physicians, microbiologists, virologists, immunologists and public health specialists came together to discuss recent approaches, developments and strategies in vaccination against worldwide pressing epidemic and endemic infectious diseases (pneumococcal, staphylococcal, influenza, papillomavirus-associated tumors, varicella-zoster, AIDS and tuberculosis), and noninfectious epidemics (atherosclerosis and smoking) outlining arguments surrounding the progress of vaccines.
PMID:
23750790
[PubMed - in process]
http://www.ncbi.nlm.nih.gov/pubmed/23750790